Cerebellum’s Align Technology ALGN Stock Holding History

Cerebellum’s Portfolio ALGN Stock Details ALGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-931	Closed	-$255K	–	424
2019 Q2	$255K	Buy	+931	New	+$281K	0.21%	334

Other funds holding ALGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cerebellum's ALGN Position: Q3 2019 in Review

Cerebellum sold out of Align Technology (ALGN) in Q3 2019, closing a stake of 931 shares — an estimated $255K sold.

Cerebellum first reported a position in ALGN in Q2 2019 and held it in 1 quarter. The position peaked at $255K in Q2 2019. 602 funds tracked by Wall St. Rank hold ALGN as of Q3 2019.

Cerebellum reported no remaining Align Technology position as of Q3 2019 after selling out during the quarter.
Cerebellum sold 931 Align Technology shares in Q3 2019, an estimated $255K.
Cerebellum first reported a position in Align Technology in Q2 2019 and held it in 1 quarter.
Cerebellum's Align Technology position peaked at $255K in Q2 2019.
602 funds tracked by Wall St. Rank held Align Technology as of Q3 2019.

Based on Cerebellum's 13F filing for Q3 2019, filed 7 Oct 2019.